摘要
目的:探讨无创通气(NIV)联合气道雾化吸入特布他林和布地奈德治疗慢性阻塞性肺疾病的临床疗效。方法:选取2017年1月~2018年1月某院收治的58慢性阻塞性肺疾病患者为研究对象,按盲选法分为研究组和对照组各29例,对照组仅采用NIV治疗,研究组在以上基础上联合使用特布他林和布地奈德气道雾化吸入治疗,对比两组临床疗效。结果:研究组治疗后动脉血气指标和RR、HR改善情况均优于对照组(P<0.05);研究组治疗总有效率高于对照组(P<0.05)。结论:在COPD治疗中应用NIV联合特布他林和布地奈德气道雾化吸入效果显著,值得应用。
Objective:To investigate the clinical efficacy of noninvasive ventilation(NIV) combined with aerosol inhalation of terbutaline and budesonide in the treatment of chronic obstructive pulmonary disease(COPD). Methods:58 patients with chronic obstructive pulmonary disease admitted to a hospital from January 2017 to January 2018 were selected as the research object. According to the method of blind selection,the patients were divided into the control group and the study group,29 patients in each group. The control group was only treated with NIV,and the study group was treated with terbutaline and budesonide aerosol inhalation on the basis of the above,and the clinical efficacy of the two groups was compared. Results:The improvement of arterial blood gas index and RR and HR in the study group was better than that in the control group(P<0.05). The total effective rate of the study group was higher than that of the control group(P<0.05). Conclusion:NIV combined with terbutaline and budesonide aerosol inhalation in the treatment of COPD is effective and worthy of application.
作者
张惠群
Zhang Huiqun(Department of Respiratory Medicine,Shunde District Longjiang Hospital,Foshan 528000)
出处
《数理医药学杂志》
2019年第10期1534-1535,共2页
Journal of Mathematical Medicine
关键词
无创通气
气道雾化吸入
特布他林
布地奈德
慢性阻塞性肺疾病
noninvasive ventilation
aerosol inhalation
terbutaline
budesonide
chronic obstructive pulmonary disease
